Senators advocate blockbuster remedy for rare drug woes

Lawmakers will soon get a chance to start pondering a bill that would dangle some blockbuster cash as an incentive to developers to take on the risk of developing new therapies for rare children's diseases. The new law, which was proffered last week, would give pharma companies a shot at quicker approvals of blockbusters if they take on new drug programs that tackle rare pediatric diseases. Adding even a few months to a drugmaker's window of market opportunity could add hundreds of millions of...